Skip to content

Metagenomic and metatranscriptomic analyses of causative pathogens in idiopathic orbital myositis

Metagenomic and metatranscriptomic analyses of causative pathogens in idiopathic orbital myositis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100047731
Enrollment
Unknown
Registered
2021-06-24
Start date
2021-01-01
Completion date
Unknown
Last updated
2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Orbital Myositis

Interventions

Myositis:Metagenomic sequencing
Control:Metagenomic sequencing

Sponsors

Fudan Eye & ENT Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: idiopathic orbital myositis within 2 months of onset; The patient typically presents with acute onset, painful diplopia, and enhancing fusiform enlargement of the muscle belly, often with involvement of the muscle tendon on CT or MRI scan

Exclusion criteria

Exclusion criteria: bilateral involvement; thyroid-associated ophthalmopathy; definite or probable IgG4-related ophthalmic diseases; cranial nerve III, IV, or VI palsy; Brown syndrome; Duane retraction syndrome; extraocular muscle tumors such as fibroma, lymphoma, and granulosa cell tumor; systemic inflammatory disease; systemic autoimmune disease; positive myositis-specific autoantibodies; paraneoplastic syndrome; drug reaction

Design outcomes

Primary

MeasureTime frame
Metagenomic sequencing;

Secondary

MeasureTime frame
Metatranscriptomic sequencing;

Countries

China

Contacts

Public ContactJiang Qian

Fudan Eye & ENT Hospital

qianjiang@fudan.edu.cn+86 21 64377134

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026